This country profile provides an overview of Mozambique’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
49%
Blinding trachoma
80%
Intestinal worms
56%
Bilharzia
96%
River blindness
NA
12.19 million
people received treatment in Mozambique in 2019
9.33 million
people did not receive treatment in Mozambique in 2019
Elephantiasis
Treatment coverage decreased from 81% in 2018 to 49% in 2019.
People needing treatment
18.06m
People receiving treatment
8.78m
Blinding trachoma
Treatment coverage increased from 20% in 2018 to 80% in 2019.
People needing treatment
4.43m
People receiving treatment
3.53m
Intestinal worms
Treatment coverage increased from 51% in 2018 to 56% in 2019.
Pre-sch and school-aged children needing treatment
10.86m
Pre-school and school-aged children receiving treatment
6.06m
Bilharzia
Treatment coverage increased from 60% in 2018 to 96% in 2019.
School-aged children needing treatment
5.96m
School-aged children receiving treatment
5.71m
River blindness
Mozambique does not require mass treatment for river blindness.
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Mozambique.